Highest-materiality recent filing
Hyperfine shareholders reelect four directors, ratify Grant Thornton as auditor
All four director nominees reelected with over 99% of votes cast (excluding broker non-votes).
Hyperfine Q1 revenue $3.9M (+83% YoY); net loss narrows to $0.09/share
Revenue $3.90M (+83% YoY); sold 10 commercial Swoop systems vs 6 in Q1 2025.
Hyperfine reports Q4 revenue up 128% YoY to $5.29M; guides FY2026 revenue $20-22M
Q4 2025 revenue $5.29M (128% YoY); net loss $5.91M ($0.06/share) vs $10.39M ($0.14) prior year.
Hyperfine secures up to $40M debt facility from Horizon Technology Finance; borrows $15M at close
Borrowed $15M at closing on March 18, 2026; additional $25M available through Dec 31, 2027.
Hyperfine reports preliminary Q4 revenue ~$5.3M (+127% YoY), FY revenue ~$13.5M (+5% YoY)
Q4 2025 revenue ~$5.3M (record quarter), +127% YoY and +54% sequential.
Hyperfine enters $50M at-the-market equity facility; adds BTIG as sales agent
Amended ATM agreement allows sale of up to $50M in Class A common stock through B. Riley and BTIG.
Hyperfine Q3 revenue $3.4M (+27% QoQ); guides Q4 rev $5-6M; net loss $11.0M
Q3 revenue $3.4M, +27% vs Q2; sold 8 commercial Swoop systems (5 next gen).
Hyperfine prices $17.5M public offering of 14M shares at $1.25/share
Offering of 14,000,000 shares of Class A common stock at $1.25 per share; gross proceeds ~$17.5M.
Hyperfine reports preliminary Q3 2025 revenue of $3.4M, up 27% sequentially
Preliminary Q3 revenue ~$3.4M, up 27% from Q2; cash and equivalents ~$21.6M as of Sept 30.
Revenue $2.7M, up 26% from Q1; sold 8 commercial Swoop systems vs 6 in Q1.
Hyperfine regains Nasdaq minimum bid price compliance
Received notice from Nasdaq on Aug 6, 2025, that it has regained compliance with the $1.00 minimum bid price requirement.
Hyperfine Chairperson Huennekens resigns; Wolterman appointed as Chair
R. Scott Huennekens resigned as Chairperson and board member, effective May 22, 2025, for personal reasons.
All six director nominees (Huennekens, Sainz, Dahldorf, Fattori, Rothberg, Wolterman) reelected with over 310M votes each.
Hyperfine Q1 revenue $2.1M, down 36% YoY; net loss $9.4M; guides FY25 growth 10-20%
Q1 revenue $2.1M vs $3.3M YoY; sold 6 commercial Swoop systems.
Hyperfine receives Nasdaq deficiency notice for bid price below $1.00 for 30 days
Nasdaq notified Hyperfine on April 30, 2025 that its closing bid price fell below $1.00 per share for 30 consecutive business days, violating Listing Rule 5450(a)(1).
FY 2024 revenue $12.89M (+17% YoY); net loss $40.72M ($0.56/share) vs $44.24M loss in 2023.
Preliminary total revenue ~$12.9M: device revenue ~$10.5M, service revenue ~$2.4M.
Hyperfine raises $6M in registered direct offering of common stock and warrants
Gross proceeds of $6.0M from sale of 4,511,278 shares and warrants at $1.33 per unit.
Hyperfine cuts 14% of workforce, expects $0.4M costs, extends cash runway to H2 2026
Terminated approximately 14% of global workforce, predominantly in technical and internally-facing roles.
Hyperfine Q3 revenue hits record $3.64M, up 56% YoY; net loss $0.14/shr
Revenue $3.64M (+56% YoY); gross margin 52% vs 48% in Q3 2023.
Hyperfine Q2 revenue record $3.63M, raises FY 2024 guidance to $13-16M
Record Q2 revenue $3.63M (+7.4% YoY); 13 commercial Swoop systems sold.
Hyperfine regains Nasdaq minimum bid price compliance; closed
Received Nasdaq deficiency notice on May 29, 2024 for bid price below $1.00 for 30 days.
Hyperfine stockholders approve Class B conversion charter amendment, reelect directors
Charter amendment adds automatic conversion of Class B common stock to Class A effective Dec 22, 2028; approved by Class A and B votes (Class B: 301.1M for, 0 against).
Hyperfine receives Nasdaq deficiency notice for bid price below $1.00
Closing bid price of HYPR common stock below $1.00 for 30 consecutive business days.
Hyperfine Q1 revenue up 25% to $3.30M; net loss narrows to $0.14/share
Revenue $3.30M, up 25% YoY from $2.64M; 13 commercial Swoop systems sold in Q1.
Hyperfine reports Q4 2023 revenue up 89% YoY to $2.69M; FY2023 net loss narrows to $44.2M
Full year 2023 revenue $11.03M (+62% YoY); Q4 revenue $2.69M (+89% YoY).
Hyperfine Q3 revenue $2.33M flat YoY; net loss narrows to $10.76M
Q3 revenue $2.33M (vs $2.35M YoY); sold 6 commercial Swoop systems in quarter.
Hyperfine signs $50M at-the-market equity offering agreement with B. Riley
Hyperfine entered into an ATM Sales Agreement with B. Riley Securities for up to $50M of Class A common stock.
Hyperfine terminates CMO/CSO Khan Siddiqui; transitions to consultant
Khan Siddiqui terminated as Chief Medical Officer and Chief Strategy Officer effective September 30, 2023.
Hyperfine Q2 2023 revenue $3.38M (record); net loss $10.64M
Revenue of $3.38M vs $1.53M in Q2 2022; sold 14 commercial Swoop systems.
Hyperfine promotes Tom Teisseyre to COO; CMO/CSO Siddiqui moves to part-time
Tom Teisseyre (formerly CPO) appointed COO effective July 24, 2023; base salary $425K, target bonus 50%, option grant of 200K shares.
Hyperfine shifts board leadership to Chairperson; stockholders approve officer liability cap
Bylaws amended to replace Executive Chairman with Chairperson; R. Scott Huennekens appointed Chairperson, Rothberg ceases as Vice Chair.
Hyperfine Q1 revenue $2.64M record; net loss narrows to $0.17/share
Revenue $2.64M, up 75% YoY from $1.51M; record quarterly revenue.
Hyperfine dismisses Deloitte, appoints Grant Thornton as auditor for FY2023
Dismissed Deloitte & Touche and appointed Grant Thornton as independent auditor for fiscal year ending Dec 31, 2023, effective March 24, 2023.
Hyperfine reports Q4 2022 revenue $1.424M; net loss $13.059M; FY2023 revenue guidance $10-14M
Q4 2022 revenue $1.424M vs $0.436M YoY; net loss per share $0.19 vs $2.73 YoY.
Hyperfine Q4 2022 revenue $1.4M, full-year $6.8M; guides FY2023 $10-14M
Full-year 2022 revenue $6.814M vs $1.496M in 2021; net loss $73.164M ($1.04 loss per share).
Hyperfine confirms zero exposure to Silicon Valley Bank after FDIC receivership
FDIC appointed receiver for Silicon Valley Bank on March 10, 2023.
Hyperfine regains Nasdaq bid price compliance; Swoop MRI receives CE Marking in EU
Nasdaq confirmed compliance with $1.00 minimum bid price rule on Feb 16, 2023; matter closed.
Hyperfine appoints Brett Hale as CAO & CFO; Alok Gupta to step down by March 31
Brett Hale becomes CAO on Feb 13, 2023 and CFO after 2022 10-K filing; Alok Gupta exits by March 31.
Hyperfine cuts ~13% of workforce; expects up to $1.7M in restructuring costs
Terminated approximately 13% of global workforce, including employees of subsidiary Liminal Sciences.
Hyperfine receives Nasdaq deficiency notice for bid price below $1.00
Nasdaq notified Hyperfine on Dec 6, 2022 that its bid price was below $1.00 for 30 straight days.
Hyperfine amends executive severance plan adding CEO, CFO, and two other officers
Participants: CEO Maria Sainz, CFO Alok Gupta, CMO/CSO Khan Siddiqui, CPO Tom Teisseyre.
Hyperfine terminates General Counsel Neela Paykel as part of restructuring
Employment of Neela Paykel (General Counsel, CCO, Corporate Secretary) terminated effective Dec 9, 2022.
Hyperfine amends executive severance plan to cover only CEO
Board amended Severance Plan effective Nov 22, 2022 to limit participation to CEO only.
Original November 14, 2022 Form 8-K erroneously reported non-compliance with Nasdaq Majority Independent Board rule.
Effective Oct 24, 2022, director Maria Sainz may no longer be considered independent under Nasdaq Rule 5605(a)(2).
Q3 2022 revenue of $2.348M vs $0.371M in Q3 2021; net loss of $13.171M ($0.19 per share).
Hyperfine names Maria Sainz President and CEO, effective Oct 24, 2022
Maria Sainz appointed CEO; base salary $550,000, target bonus 90%, sign-on $125,000.
Option repricing covers up to 5,496,799 shares of Class A common stock held by eligible employees, including execs.
Hyperfine Q2 revenue up 328% YoY to $1.5M; net loss $23.2M ($0.33/shr)
Revenue $1.533M (Q2 2022) vs $0.358M (Q2 2021); gross margin negative at ($0.165M).
R. Scott Huennekens, Chairperson of the Board of Directors (the “Board”) of Hyperfine, Inc. (the “Company”), notified the Company of his decision to resign as Chairperson and member of the Board, effective as of May 22, 2025
the Board appointed Daniel J. Wolterman, a current member of the Board, as Chairperson of the Board.
On September 27, 2023, Hyperfine, Inc. (the “Company”) terminated Khan Siddiqui, M.D.’s part-time employment as the Company’s Chief Medical Officer and Chief Strategy Officer, effective September 30, 2023
the Company entered into a schedule and salary modification letter agreement (the “Modification Agreement”) with Khan Siddiqui, M.D., the Company’s Chief Medical Officer and Chief Strategy Officer, effective July 24, 2023.
Thomas Teisseyre, Ph.D., the Company’s Chief Product Officer, has been appointed by the Board of Directors of the Company (the “Board”) to serve as Chief Operating Officer of the Company, effective as of July 24, 2023
On February 8, 2023, Hyperfine, Inc. (the “Company”) announced that Brett Hale has been appointed by the Board of Directors of the Company (the “Board”) to serve as Chief Administrative Officer of the Company, effective as of February 13, 2023
On February 3, 2023, the Company determined that the employment of Alok Gupta, the Company’s current Chief Financial Officer, will terminate effective as of March 31, 2023.
terminated the employment of Neela Paykel as General Counsel, Chief Compliance Officer, and Corporate Secretary of the Company, effective December 9, 2022.
On October 6, 2022, Hyperfine, Inc. (the 'Company') announced that Maria Sainz, one of the Company’s current directors, was appointed by the Board of Directors of the Company (the 'Board') as President and Chief Executive Officer of the Company, effective as of October 24, 2022
R. Scott Huennekens, who has been serving as Interim President and Chief Executive Officer of the Company, will step down from that role effective as of the Appointment Date. Mr. Huennekens will continue to serve as Executive Chairperson of the Board.
the Board of Directors (the “Board”) of Hyperfine, Inc. (the “Company”) appointed R. Scott Huennekens as Interim President and Chief Executive Officer of the Company, effective as of July 29, 2022.
On June 27, 2022, Dave Scott delivered his resignation as Hyperfine, Inc.’s (the “Company”) President, Chief Executive Officer and a member of the Board of Directors (the “Board”), effective July 29, 2022.
Max materiality 0.75 · Median 0.60 · Most common event earnings